Insider Transactions in Q3 2022 at Protara Therapeutics, Inc. (TARA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,300
+0.95%
|
$21,900
$3.8 P/Share
|
|
Sep 14
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,600
+1.22%
|
$49,800
$3.98 P/Share
|
|
Aug 11
2022
|
Jesse Shefferman CEO and President |
BUY
Open market or private purchase
|
Direct |
9,065
+1.02%
|
$27,195
$3.84 P/Share
|
|
Jul 16
2022
|
Hannah Fry VP, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+47.53%
|
-
|
|
Jul 15
2022
|
Blaine Davis Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,081
-19.74%
|
$15,243
$3.13 P/Share
|
|
Jul 01
2022
|
Jathin Bandari Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-3.25%
|
$2,046
$3.22 P/Share
|